Other Events ·
On June 11, 2026, Natera, Inc. held its Annual Meeting of Stockholders, where shareholders approved an amendment to…
NTRANatera, Inc.
On June 11, 2026, Natera, Inc. held its Annual Meeting of Stockholders, where shareholders approved an amendment to the Amended and Restated 2015 Equity Incentive Plan. This amendment increases the shares reserved for issuance under the plan by 3.2 million shares of common stock. Other routine matters, including the election of directors Rowan Chapman, Herm Rosenman, Jonathan Sheena, and Eric H. Rubin, the ratification of Ernst & Young LLP as independent auditor, and advisory votes on executive compensation, were also approved. Natera operates in the healthcare industry, providing genetic testing and diagnostics.